Pfizer Inc.
PFE
$27.05
$0.291.08%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 63.70B | 63.31B | 62.58B | 62.79B | 63.83B |
| Total Other Revenue | 1.00M | 1.00M | -- | -1.00M | 0.00 |
| Total Revenue | 63.70B | 63.32B | 62.58B | 62.79B | 63.83B |
| Cost of Revenue | 16.11B | 15.95B | 15.14B | 16.59B | 17.48B |
| Gross Profit | 47.59B | 47.36B | 47.44B | 46.20B | 46.35B |
| SG&A Expenses | 12.92B | 12.95B | 13.02B | 14.03B | 14.06B |
| Depreciation & Amortization | 4.82B | 4.85B | 4.88B | 5.00B | 5.09B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.86B | 44.46B | 43.47B | 45.84B | 46.92B |
| Operating Income | 18.84B | 18.85B | 19.11B | 16.95B | 16.91B |
| Income Before Tax | 4.21B | 7.91B | 7.52B | 9.15B | 10.53B |
| Income Tax Expenses | -164.00M | 384.00M | -266.00M | -685.00M | -235.00M |
| Earnings from Continuing Operations | 4.37K | 7.52K | 7.79K | 9.84K | 10.77K |
| Earnings from Discontinued Operations | -5.00M | 12.00M | 25.00M | 32.00M | 24.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -35.00M | -43.00M | -41.00M | -41.00M | -40.00M |
| Net Income | 4.33B | 7.49B | 7.77B | 9.83B | 10.75B |
| EBIT | 18.84B | 18.85B | 19.11B | 16.95B | 16.91B |
| EBITDA | 25.38B | 25.40B | 25.66B | 23.63B | 23.68B |
| EPS Basic | 0.76 | 1.32 | 1.37 | 1.73 | 1.89 |
| Normalized Basic EPS | 2.08 | 2.05 | 2.09 | 1.69 | 1.65 |
| EPS Diluted | 0.75 | 1.31 | 1.36 | 1.72 | 1.89 |
| Normalized Diluted EPS | 2.08 | 2.04 | 2.08 | 1.68 | 1.64 |
| Average Basic Shares Outstanding | 22.76B | 22.75B | 22.73B | 22.71B | 22.69B |
| Average Diluted Shares Outstanding | 22.83B | 22.84B | 22.82B | 22.83B | 22.82B |
| Dividend Per Share | 2.15 | 2.15 | 2.15 | 2.13 | 2.12 |
| Payout Ratio | 225.88% | 97.92% | 94.29% | 73.88% | 66.94% |